Shak S - Search Results

1

Dose-dependent in vitro effect of recombinant human DNase on rheological and transport properties of cystic fibrosis respiratory mucus.

Zahm JM, Girod de Bentzmann S, Deneuville E, Perrot-Minnot C, Dabadie A, Pennaforte F, Roussey M, Shak S, Puchelle E. Zahm JM, et al. Among authors: shak s. Eur Respir J. 1995 Mar;8(3):381-6. doi: 10.1183/09031936.95.08030381. Eur Respir J. 1995. PMID: 7789481 Free article.

2

Effects of rhDNase on purulent airway secretions in chronic bronchitis.

Puchelle E, Zahm JM, de Bentzmann S, Grosskopf C, Shak S, Mougel D, Polu JM. Puchelle E, et al. Among authors: shak s. Eur Respir J. 1996 Apr;9(4):765-9. doi: 10.1183/09031936.96.09040769. Eur Respir J. 1996. PMID: 8726943 Free article.

3

Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.

Shak S. Shak S. Chest. 1995 Feb;107(2 Suppl):65S-70S. doi: 10.1378/chest.107.2_supplement.65s. Chest. 1995. PMID: 7842816 Review.

4

Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.

Ranasinha C, Assoufi B, Shak S, Christiansen D, Fuchs H, Empey D, Geddes D, Hodson M. Ranasinha C, et al. Among authors: shak s. Lancet. 1993 Jul 24;342(8865):199-202. doi: 10.1016/0140-6736(93)92297-7. Lancet. 1993. PMID: 8100928 Clinical Trial.

5

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL. Shak S, et al. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9188-92. doi: 10.1073/pnas.87.23.9188. Proc Natl Acad Sci U S A. 1990. PMID: 2251263 Free PMC article.

6

Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study.

Aitken ML, Burke W, McDonald G, Shak S, Montgomery AB, Smith A. Aitken ML, et al. Among authors: shak s. JAMA. 1992 Apr 8;267(14):1947-51. JAMA. 1992. PMID: 1548827 Clinical Trial.

7

Engineering actin-resistant human DNase I for treatment of cystic fibrosis.

Ulmer JS, Herzka A, Toy KJ, Baker DL, Dodge AH, Sinicropi D, Shak S, Lazarus RA. Ulmer JS, et al. Among authors: shak s. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8225-9. doi: 10.1073/pnas.93.16.8225. Proc Natl Acad Sci U S A. 1996. PMID: 8710851 Free PMC article.

8

A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.

Hubbard RC, McElvaney NG, Birrer P, Shak S, Robinson WW, Jolley C, Wu M, Chernick MS, Crystal RG. Hubbard RC, et al. Among authors: shak s. N Engl J Med. 1992 Mar 19;326(12):812-5. doi: 10.1056/NEJM199203193261207. N Engl J Med. 1992. PMID: 1538726 Free article. Clinical Trial. No abstract available.

9

[rhDNase: scientific background, cloning and production].

Shak S. Shak S. Arch Pediatr. 1995 Jul;2(7):666-9. doi: 10.1016/0929-693x(96)81223-1. Arch Pediatr. 1995. PMID: 7663657 Review. French.

10

Colorimetric determination of DNase I activity with a DNA-methyl green substrate.

Sinicropi D, Baker DL, Prince WS, Shiffer K, Shak S. Sinicropi D, et al. Among authors: shak s. Anal Biochem. 1994 Nov 1;222(2):351-8. doi: 10.1006/abio.1994.1502. Anal Biochem. 1994. PMID: 7864358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters